Last edition
News about "Olezarsen severe hypertriglyceridemia"
EU Recommends Ionis Pharma's TRYNGOLZA for CHMP Approval
Ionis Pharma's TRYNGOLZA has received CHMP recommendation for EU approval to treat severe hypertriglyceridemia, potentially becoming the first RNA-targeted therapy.
Olezarsen Severe Hypertriglyceridemia | 17/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members